Scientists describe potential antibody treatment for multidrug-resistant K. pneumoniae

ScienceDaily | 3/13/2018 | Staff
xhelloworld (Posted by) Level 4
Klebsiella bacteria cause about 10 percent of all hospital-acquired infections in the United States. A carbapenem-resistant K. pneumoniae strain known as multilocus sequence type 258 (ST258) is one of the antibiotic-resistant organisms labeled an urgent threat by the Centers for Disease Control and Prevention. ST258 is particularly concerning because it is resistant to most antibiotics. It is a significant cause of mortality among people with bloodstream infections.

The researchers first determined that the bacterial capsule prevents immune system neutrophils from ingesting and killing ST258. They then extracted capsule from the two most abundant capsule types of ST258 and used them to generate antibodies...
(Excerpt) Read more at: ScienceDaily
Wake Up To Breaking News!
"However, when the Son of Man comes, will he find faith on the earth?" Luke 18:8
Sign In or Register to comment.

Welcome to Long Room!

Where The World Finds Its News!